Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients receiving additional induction chemotherapy

To clarify the optimal cumulative cisplatin dose (CCD) in locoregionally‐advanced nasopharyngel carcinoma (NPC) patients receiving induction chemotherapy (IC) plus concurrent chemoradiotherapy (CCRT). Using the NPC‐specific database from the established big‐data intelligence platform at Sun Yat‐Sen...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Sci
Main Authors: Lv, Jia‐Wei, Qi, Zhen‐Yu, Zhou, Guan‐Qun, He, Xiao‐Jun, Chen, Yu‐Pei, Mao, Yan‐Ping, Chen, Lei, Tang, Ling‐Long, Li, Wen‐Fei, Lin, Ai‐Hua, Ma, Jun, Sun, Ying
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2018
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5834779/
https://ncbi.nlm.nih.gov/pubmed/29266526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13474
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares